Infutraze

Zinc chloride, potassium iodide, sodium selenite, copper chloride dihydrate, manganese chloride tetr, the active ingredients in Infutraze, is a trace element supplement presented as an intravenous solution for intravenous use. It is indicated for correction of trace element deficiency and supports patients receiving parenteral nutrition. GNH USA supplies Infutraze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Infutraze is used to address deficiencies of essential trace elements in patients requiring parenteral support. - Trace element deficiency: restores zinc, iodine, selenium, copper and manganese to physiologic levels. - Parenteral nutrition support: provides the necessary trace elements for patients on total parenteral nutrition. - Critical illness or postoperative care: helps maintain enzymatic activity during periods of high metabolic stress.

Infutraze may be associated with a range of adverse reactions.

Common Side Effects: - Injection site pain or erythema. - Transient metallic taste. - Mild nausea or vomiting. - Headache. - Low‑grade fever.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction. - Significant electrolyte imbalance (e.g., copper or zinc overload). - Acute renal dysfunction. - Hepatotoxicity or liver enzyme elevation.

Use of Infutraze requires careful clinical assessment and monitoring. - Renal impairment: monitor serum trace element concentrations and renal function. - Hepatic dysfunction: observe liver enzymes during therapy. - Pregnancy: administer only if potential benefit justifies the risk. - Concurrent parenteral nutrition: avoid duplicate supplementation of trace elements. - Known hypersensitivity: discontinue immediately if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Infutraze can interact with other medications and supplements that affect trace element balance.

Major Interactions (Avoid): - High‑dose oral zinc supplements: may precipitate copper deficiency. - Thyroid hormone therapy: excess iodine can alter thyroid hormone levels.

Moderate Interactions (Monitor Closely): - Loop or thiazide diuretics: may modify electrolyte status. - Anticoagulants: trace elements can influence coagulation pathways. - Certain chemotherapy agents: potential additive toxicity requiring closer monitoring.